Clinical Trials Directory

Trials / Completed

CompletedNCT03622151

Homeless Population and Mental Health: Impact of Primer la Llar Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Parc Sanitari Sant Joan de Déu · Academic / Other
Sex
All
Age
18 Years – 72 Years
Healthy volunteers
Not accepted

Summary

The main goal is to evaluate the impact of the Primer La Llar housing program for the homeless population on the mental health of the participants. The hypothesis is that the housing program, which follows Housing first model, for the homeless population has a positive impact on the mental health of the participants, compared to the group that does not receive the intervention -treatment as usual group (meaning the "positive impact" a lower score on the symptomatology scales and lower toxic intake in the group receiving the intervention).

Detailed description

The specific objectives are: Identify the socio-demographic and clinical characteristics of the participants. Compare the severity of psychiatric symptoms and improvement among the participants in the intervention group and the control group (depressive, anxious, psychotic or manic symptomatology, depending on the case). Compare the consumption of alcohol and drugs among the participants of both groups. Compare the basic daily life skills among the participants in both groups, as well as the improvement of them in the experimental group. Compare the use of services and between the participants of the intervention group and the control group. Intervention group receives entry to the program (which means individual and permanent housing without previous requirements such as abstinence, compliance with treatment or sobriety. Control group receives treatment as usual, as they are users of homeless population network of Barcelona.

Conditions

Interventions

TypeNameDescription
OTHERPrimer la Llar programHousing First model: permanent housing without previous requirements such as abstinence, sobriety or compliance with treatment.

Timeline

Start date
2016-01-01
Primary completion
2017-01-01
Completion
2018-05-01
First posted
2018-08-09
Last updated
2018-10-02

Source: ClinicalTrials.gov record NCT03622151. Inclusion in this directory is not an endorsement.